INCY
Incyte Corp Health Care Services-Commercial Physical & Biological Research S&P 500Russell 3000
$120.39Close
$23.9BMarket cap
$90.30 – $129.9352-week range
Late-januaryNext report · estimated
Highlights
Cautions
- Trend not confirmed 7 of 8 conditions · under the 50-day
- Earnings shrinking EPS −283% year on year
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
up 4.0%
price change
1mo
down 0.8%
price change
12-month return
up 30%
market up 11% ·
its own up 23%
F-score
8 / 9
Exceptional
Altman Z″
7.90
Low risk
P/E
18.6×
price / earnings
PEG
0.00
P/E / EPS growth
P/B
4.6×
price / book
Earnings yield
up 7.3%
EBIT / enterprise value
Cheaper than
65%
of the market · cheap
Revenue growth
up 21%
year on year
EPS growth
down 283%
latest quarter · -321 pts
Sales growth
up 14%
latest quarter · -24 pts
ROE
up 30%
return on equity
Free cash margin
up 27%
$1.4B FCF
D/E
—
long-term debt / equity
Net debt / EBITDA
-1.9×
net cash
Interest cover
—EBIT / interest
Piotroski tests
- issued more shares
- profitable on its assets
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- short-term liquidity improved
- gross margin widened
- assets working harder
Trade setup
ATR%
3.1%
$3.79 a day · 2×ATR $112.81
RS
72 / 99
vs the universe
Trend
7 / 8
under the 50-day
Relative volume
1.8×
vs 50-day average
Up/down volume
0.68
50 sessions
Implied move
—
no scheduled report
Trend template · 7 of 8
- Price above the 50-day average: fails
Screen verdict
Did not qualify for any screen.
Warning signs
- Shareholders diluted The share count rose 2.6% over the year, from 193m to 198m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Oct 29, 2026
Results reaction
Oct 29, 2026+5% vs market2 sessions after results
Options
$678,65438.4% IV · activity
Financials
- Gross 93%
- Net 25%
- Free cash 27%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $2.7B | $3.0B | $3.4B | $3.7B | $4.2B | $5.1B |
| Gross margin | 95% | 95% | 94% | 93% | 93% | 93% |
| Operating income | -$263.7M | $585.8M | $579.4M | $620.5M | $61.4M | $1.5B |
| Net income | -$295.7M | $948.6M | $340.7M | $597.6M | $32.6M | $1.3B |
| Net margin | -11% | 32% | 10% | 16% | 1% | 25% |
| Earnings per share | -$1.36 | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 |
| Free cash flow | -$312.0M | $568.5M | $892.1M | $496.5M | $335.3M | $1.4B |
| Free cash margin | -12% | 19% | 26% | 13% | 8% | 27% |
| Cash | $1.5B | $2.1B | $3.0B | $3.2B | $1.7B | $3.1B |
| Shareholders' equity | $2.6B | $3.8B | $4.4B | $5.2B | $3.4B | $5.2B |
| Shares outstanding | 219.49m | 221.08m | 222.75m | 224.29m | 193.43m | 198.46m |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $112 – $129 ±7.1% by Nov 20, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- Bigger 38.4% priced · 30.1% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- About the same
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: costs more
Positioning
- Premium traded
- $678,654 calls $272,366 · puts $406,288 · latest session
- 1.49× +1.46 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls +668 · puts -423 past week
For options traders: ATM IV 38.4% (-11.1% 1w) · 1m ÷ 3m IV 1.01 · 25Δ skew 7.0 pts · Net GEX -$788,031
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Jul 28, 2026 | Quarterly ↗ | Jun 30, 2026 | 28d |
| Apr 28, 2026 | Quarterly ↗ | Mar 31, 2026 | 28d |
| Feb 10, 2026 | Annual ↗ | Dec 31, 2025 | 41d |
| Oct 28, 2025 | Quarterly ↗ | Sep 30, 2025 | 28d |
| Jul 29, 2025 | Quarterly ↗ | Jun 30, 2025 | 29d |
| Apr 29, 2025 | Quarterly ↗ | Mar 31, 2025 | 29d |
| Feb 10, 2025 | Annual ↗ | Dec 31, 2024 | 41d |
| Oct 29, 2024 | Quarterly ↗ | Sep 30, 2024 | 29d |
| Jul 30, 2024 | Quarterly ↗ | Jun 30, 2024 | 30d |
| Apr 30, 2024 | Quarterly ↗ | Mar 31, 2024 | 30d |
| Feb 13, 2024 | Annual ↗ | Dec 31, 2023 | 44d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Aug 31, 2026 | Other events ↗ |
| Jul 28, 2026 | Results ↗ |
| Jul 6, 2026 | Other events ↗ |
| Jun 22, 2026 | Other events ↗ |
| Jun 9, 2026 | Shareholder vote ↗ |
| Jun 8, 2026 | Other events ↗ |
| Apr 28, 2026 | Results ↗ |
| Mar 30, 2026 | Director or officer change ↗ |
| Mar 26, 2026 | Director or officer change ↗ |
| Mar 6, 2026 | Other events ↗ |
| Feb 10, 2026 | Results ↗ |